Esempio: Heart Attack

Cerca studi clinici per: Paroxetine

Totale 266 risultati

NCT03504475

Completato

Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

Condizioni: Major Depressive Disorder; Obsessive-Compulsive Disorder; Panic Disorder; Social Anxiety Disorder; Generalized Anxiety Disorder
NCT03274752

Attivo, non reclutamento

Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction

Condizioni: Cardiac Remodeling; Myocardial Infarction
NCT01829919

Completato

Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women

Condizioni: Postmenopausal Symptoms
NCT04311463

Completato

Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants

Condizioni: Anxiety Disorders
NCT01841502

Terminato

Interaction Between Paroxetine and Telaprevir

Condizioni: Hepatitis C Infection; Depression
NCT02681198

Completato

Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers

Condizioni: Healthy
NCT01916200

Ritirato

Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients

Condizioni: Depressive Disorder
NCT01416220

Completato

Lithium Versus Paroxetine in Major Depression

Condizioni: Major Depressive Disorder
NCT04757571

Reclutamento

The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients

Condizioni: Rheumatoid Arthritis
NCT00406432

Completato

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

Condizioni: Depressive Disorder
NCT00610610

Completato

Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome

Condizioni: Fibromyalgia Syndrome
NCT02852577

Completato

Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine

Condizioni: Panic Disorder; Agoraphobia
NCT01458626

Completato

Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement

Condizioni: Major Depression
NCT00560612

Completato

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

Condizioni: Stress Disorders, Post-Traumatic
NCT00184106

Completato

RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo

Condizioni: Phobic Disorders
NCT00368303

Completato

A Local Register Study For Major Depression Of Paroxetine Controlled Release

Condizioni: Depressive Disorder, Major; Major Depressive Disorder (MDD)
NCT00246441

Completato

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Condizioni: Social Anxiety Disorder; Social Phobia; Alcohol Use Disorder; Alcohol Abuse; Alcohol Dependence
NCT01376271

Completato

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

Condizioni: Social Phobia
NCT01159821

Completato

A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers

Condizioni: Healthy
NCT03894085

Reclutamento

Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment

Condizioni: Anxiety Disorder; Obsessive-Compulsive Disorder
NCT01361308

Completato

Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)

Condizioni: Postmenopausal Symptoms
NCT01101841

Completato

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

Condizioni: Hot Flashes
NCT00516113

Completato

A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria

Condizioni: Premenstrual Dysphoric Disorder; Premenstrual Syndrome
NCT00620581

Completato

Luteal Phase Administration of Paroxetine for the Treatment of PMDD

Condizioni: Premenstrual Dysphoric Disorder
NCT00786188

Completato

Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause

Condizioni: Hot Flashes